FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385669979> ?p ?o ?g. }

• W4385669979 endingPage "S831" @default.
• W4385669979 startingPage "S831" @default.
• W4385669979 abstract "Introduction Both in consultations with the general practitioner and with the psychiatrist, antidepressants are one of the most used drugs (1). These have multiple indications, and there are different groups according to their mechanism of action. In relation to this case, we are going to talk about Venlafaxine, a dual-type antidepressant, that is, it inhibits the reuptake of serotonin and norepinephrine. One of the most common side effects is digestive discomfort, which usually resolves after a few weeks (2). However, we should not ignore these symptoms, since they can hide something more serious. Objectives Presentation of a clinical case on a patient who presented an increase in pancreatic amylase after starting treatment with Venlafaxine. Methods Bibliographic review including the latest articles in Pubmed on side effects of antidepressant treatment, and more specifically at the gastrointestinal level (in this case we will talk about pancreatitis). Results We present the case of a 49-year-old woman, who was hospitalized 2 years ago, due to a first depressive episode. During this admission, psychopharmacological treatment was started for the first time, on that occasion with a selective serotonin reuptake inhibitor (SSRI), treatment of first choice (3). The patient had no side effects at that time, but the response was very modest, so it was decided to replace that antidepressant with Venlafaxine (with dual action), up to 150mg. The depressive symptoms improved markedly, however the patient began to feel digestive discomfort (which at first did not seem to be of great importance). A general analysis was performed, in which an increase in lipase (978 U/L) and amylase (528 U/L) was detected. An echoendoscopy, an abdominal scan, and a magnetic resonance cholangiography were performed; Pancreatitis secondary to drugs was suspected (a severe condition). Luckily, no significant lesions were found in the tests, and the levels of amylase and lipase decreased when Venlafaxine treatment was withdrawn (without reaching the normal range). The patient was discharged and continued to attend consultations. In the last control, amylase had dropped to 225 U/L. His abdominal pain disappeared. Treatment with Vortioxetine (a multimodal antidepressant) was started, however the amylase levels continue to be monitored, and the patient continues to see the gastroenterologist. Conclusions Gastrointestinal side effects are very common when taking antidepressant treatment, and in most cases they do not usually represent a serious problem. However, it is described in the scientific literature that in some cases, acute pancreatitis secondary to some drugs, including Venlafaxine, can occur (4). In order to detect it, it is necessary to perform a blood test and sometimes also other complementary tests. For its treatment, the fundamental thing is to withdraw the causing drug, trying to find other alternatives, and carry out a control to monitor possible complications Disclosure of Interest None Declared" @default.
• W4385669979 created "2023-08-09" @default.
• W4385669979 creator A5002485696 @default.
• W4385669979 creator A5011288083 @default.
• W4385669979 creator A5039788450 @default.
• W4385669979 creator A5042183798 @default.
• W4385669979 creator A5043661028 @default.
• W4385669979 creator A5043855411 @default.
• W4385669979 creator A5048173880 @default.
• W4385669979 creator A5057690594 @default.
• W4385669979 creator A5070245282 @default.
• W4385669979 creator A5070522786 @default.
• W4385669979 creator A5070643310 @default.
• W4385669979 creator A5074412614 @default.
• W4385669979 creator A5075763510 @default.
• W4385669979 creator A5082359442 @default.
• W4385669979 creator A5087265233 @default.
• W4385669979 creator A5092614841 @default.
• W4385669979 creator A5092614842 @default.
• W4385669979 date "2023-03-01" @default.
• W4385669979 modified "2023-10-12" @default.
• W4385669979 title "“Keeping an eye on amylase”. Side effects of antidepressants" @default.
• W4385669979 doi "https://doi.org/10.1192/j.eurpsy.2023.1760" @default.
• W4385669979 hasPublicationYear "2023" @default.
• W4385669979 type Work @default.
• W4385669979 citedByCount "1" @default.
• W4385669979 countsByYear W43856699792023 @default.
• W4385669979 crossrefType "journal-article" @default.
• W4385669979 hasAuthorship W4385669979A5002485696 @default.
• W4385669979 hasAuthorship W4385669979A5011288083 @default.
• W4385669979 hasAuthorship W4385669979A5039788450 @default.
• W4385669979 hasAuthorship W4385669979A5042183798 @default.
• W4385669979 hasAuthorship W4385669979A5043661028 @default.
• W4385669979 hasAuthorship W4385669979A5043855411 @default.
• W4385669979 hasAuthorship W4385669979A5048173880 @default.
• W4385669979 hasAuthorship W4385669979A5057690594 @default.
• W4385669979 hasAuthorship W4385669979A5070245282 @default.
• W4385669979 hasAuthorship W4385669979A5070522786 @default.
• W4385669979 hasAuthorship W4385669979A5070643310 @default.
• W4385669979 hasAuthorship W4385669979A5074412614 @default.
• W4385669979 hasAuthorship W4385669979A5075763510 @default.
• W4385669979 hasAuthorship W4385669979A5082359442 @default.
• W4385669979 hasAuthorship W4385669979A5087265233 @default.
• W4385669979 hasAuthorship W4385669979A5092614841 @default.
• W4385669979 hasAuthorship W4385669979A5092614842 @default.
• W4385669979 hasBestOaLocation W43856699791 @default.
• W4385669979 hasConcept C118552586 @default.
• W4385669979 hasConcept C15744967 @default.
• W4385669979 hasConcept C199360897 @default.
• W4385669979 hasConcept C2776466888 @default.
• W4385669979 hasConcept C2779177272 @default.
• W4385669979 hasConcept C2909532165 @default.
• W4385669979 hasConcept C3454156 @default.
• W4385669979 hasConcept C41008148 @default.
• W4385669979 hasConcept C558461103 @default.
• W4385669979 hasConcept C71924100 @default.
• W4385669979 hasConceptScore W4385669979C118552586 @default.
• W4385669979 hasConceptScore W4385669979C15744967 @default.
• W4385669979 hasConceptScore W4385669979C199360897 @default.
• W4385669979 hasConceptScore W4385669979C2776466888 @default.
• W4385669979 hasConceptScore W4385669979C2779177272 @default.
• W4385669979 hasConceptScore W4385669979C2909532165 @default.
• W4385669979 hasConceptScore W4385669979C3454156 @default.
• W4385669979 hasConceptScore W4385669979C41008148 @default.
• W4385669979 hasConceptScore W4385669979C558461103 @default.
• W4385669979 hasConceptScore W4385669979C71924100 @default.
• W4385669979 hasIssue "S1" @default.
• W4385669979 hasLocation W43856699791 @default.
• W4385669979 hasOpenAccess W4385669979 @default.
• W4385669979 hasPrimaryLocation W43856699791 @default.
• W4385669979 hasRelatedWork W1972736647 @default.
• W4385669979 hasRelatedWork W1979587949 @default.
• W4385669979 hasRelatedWork W2064158398 @default.
• W4385669979 hasRelatedWork W2110677903 @default.
• W4385669979 hasRelatedWork W2321488592 @default.
• W4385669979 hasRelatedWork W2325424279 @default.
• W4385669979 hasRelatedWork W2329766904 @default.
• W4385669979 hasRelatedWork W2367775454 @default.
• W4385669979 hasRelatedWork W2792828356 @default.
• W4385669979 hasRelatedWork W4385669979 @default.
• W4385669979 hasVolume "66" @default.
• W4385669979 isParatext "false" @default.
• W4385669979 isRetracted "false" @default.
• W4385669979 workType "article" @default.